ATE121459T1 - Antibiotika ge 2270 faktoren b1, b2, c1, d1, d2, e und t. - Google Patents

Antibiotika ge 2270 faktoren b1, b2, c1, d1, d2, e und t.

Info

Publication number
ATE121459T1
ATE121459T1 AT91103055T AT91103055T ATE121459T1 AT E121459 T1 ATE121459 T1 AT E121459T1 AT 91103055 T AT91103055 T AT 91103055T AT 91103055 T AT91103055 T AT 91103055T AT E121459 T1 ATE121459 T1 AT E121459T1
Authority
AT
Austria
Prior art keywords
factors
antibiotics
antibiotic
medicaments
directed
Prior art date
Application number
AT91103055T
Other languages
English (en)
Inventor
Enrico Selva
Paolo Tavecchia
Ermenegildo Restelli
Pietro Ferrari
Maurizio Denaro
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of ATE121459T1 publication Critical patent/ATE121459T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P23/00—Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91103055T 1990-03-08 1991-03-01 Antibiotika ge 2270 faktoren b1, b2, c1, d1, d2, e und t. ATE121459T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90104409 1990-03-08
EP90120214 1990-10-22

Publications (1)

Publication Number Publication Date
ATE121459T1 true ATE121459T1 (de) 1995-05-15

Family

ID=26125004

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91103055T ATE121459T1 (de) 1990-03-08 1991-03-01 Antibiotika ge 2270 faktoren b1, b2, c1, d1, d2, e und t.

Country Status (11)

Country Link
US (2) US5747295A (de)
EP (1) EP0451486B1 (de)
JP (1) JP3107584B2 (de)
KR (1) KR0165684B1 (de)
AT (1) ATE121459T1 (de)
CA (1) CA2037779C (de)
DE (1) DE69108972T2 (de)
DK (1) DK0451486T3 (de)
ES (1) ES2071143T3 (de)
GR (1) GR3015899T3 (de)
IE (1) IE67973B1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69224497T2 (de) * 1991-08-30 1998-07-02 Biosearch Italia Spa Faktor C2a des Antibiotikums CE 2270
US5882900A (en) * 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
WO1996014427A1 (en) * 1994-11-08 1996-05-17 Gruppo Lepetit S.P.A. Microbial transformation process for obtaining antibiotic ge 2270 factor d¿2?
ATE165101T1 (de) * 1995-02-07 1998-05-15 Biosearch Italia Spa Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
JP3518606B2 (ja) * 1995-02-07 2004-04-12 バイオサーチ・イタリア・ソチエタ・ペル・アチオニ Ge2270及びge2270−様抗生物質の塩基性オキサゾリン−アミド誘導体
EP0880541B1 (de) * 1996-02-14 2003-01-15 Biosearch Italia S.p.A. Derivate des antibiotisch wirkenden faktors ge2270
DE102004031656A1 (de) * 2004-06-30 2006-01-19 Merck Patent Gmbh Tetrahydrochinoline
PE20080103A1 (es) * 2006-05-31 2008-04-03 Novartis Ag AMINOTIAZOLES COMO MODULADORES DEL FACTOR DE ELONGACION EF-Tu
WO2008082562A2 (en) * 2006-12-20 2008-07-10 Novartis Ag Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production
AU2008258639B2 (en) 2007-06-04 2012-07-05 Novartis Ag Macrocycles and their uses
CA2708793C (en) 2007-12-12 2016-06-21 Novartis Ag Aminothiazoles and their uses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2399247A1 (fr) * 1977-08-04 1979-03-02 Rhone Poulenc Ind Antibiotique 35665 rp, sa preparation et les compositions qui les contiennent
GB8821160D0 (en) * 1988-09-09 1988-10-12 Lepetit Spa Antibiotic ge 2270
US5202241A (en) * 1988-09-09 1993-04-13 Gruppo Lepetit S.P.A. Antibiotic GE 2270
ES2066914T3 (es) * 1989-07-04 1995-03-16 Lepetit Spa Factores a1, a2, a3 y h del antibiotico ge 2270.
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
DE69224497T2 (de) * 1991-08-30 1998-07-02 Biosearch Italia Spa Faktor C2a des Antibiotikums CE 2270
EP0880541B1 (de) * 1996-02-14 2003-01-15 Biosearch Italia S.p.A. Derivate des antibiotisch wirkenden faktors ge2270

Also Published As

Publication number Publication date
IE67973B1 (en) 1996-05-15
EP0451486A1 (de) 1991-10-16
CA2037779C (en) 2002-11-05
DE69108972T2 (de) 1995-10-19
US5843890A (en) 1998-12-01
DK0451486T3 (da) 1995-05-08
GR3015899T3 (en) 1995-07-31
IE910754A1 (en) 1991-09-11
ES2071143T3 (es) 1995-06-16
DE69108972D1 (de) 1995-05-24
JP3107584B2 (ja) 2000-11-13
CA2037779A1 (en) 1991-09-09
KR910016938A (ko) 1991-11-05
JPH04217988A (ja) 1992-08-07
KR0165684B1 (ko) 1999-01-15
EP0451486B1 (de) 1995-04-19
US5747295A (en) 1998-05-05

Similar Documents

Publication Publication Date Title
BR1100089A (pt) Novas sulfonilaminopirimidinas, sua preparação e emprego como medicamento
BR9611400A (pt) "agentes antimicobiano de benzoxazina".
DE68917163D1 (de) Antibakterielle Mittel.
DE69108972D1 (de) Antibiotika GE 2270 Faktoren B1, B2, C1, D1, D2, E und T.
DE3682767D1 (de) Antibiotika-a40926-n-acylaminoglycuronyl-aglykone und antibiotika-a40926-aglykone.
DE3683266D1 (de) Antibiotikum a 40926 mannosyl aglycon.
DE69016284D1 (de) Antibiotikum GE 22270, Faktoren A1,A2,A3 und H.
DK312688A (da) Glykkopeptid-antibiotika
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
DE68926972D1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische Anwendungen
ES2113391T3 (es) Factor c2a de antibiotico ge 2270.
BR9306207A (pt) Composiçao farmacéutica e processo para o tratamento de infecçao ou doença causada pelo vírus da hepatite b processo para a preparaçao da composiçao e uso de fiau ou de uma pró-droga ou metabolito do mesmo
ATE147757T1 (de) Propanolamin-cyclohexapeptide
DE69317058D1 (de) Die antibiotika ge 37468 a, b und c
EP0359062A3 (de) Antibiotikum GE 2270
DE69004941D1 (de) Arzneimittelformulierungen zum Erhöhen der Wirksamkeit von Betalaktamantibiotika in Prophylaxe und Behandlung von infektiöser Krankheit infolge pathogener Bakterien.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee